The Paediatric HIV response

Children affected by HIV/AIDS at the Sisonke project
Reflection: The paediatric HIV response in the context of AIDS optimism
Reflections on the Epidemic - World AIDS Day 2012 series
A series of articles by guest writers for World AIDS Day

Part of AVERT's World AIDS Day 2012 campaign, ‘Reflections on the Epidemic’ are a series of articles by guest writers. Our guest writers range from global leaders, writers, experts, activists, physicians and people personally affected by HIV and AIDS; and they represent various countries, experiences and backgrounds from all over the world. We are grateful to all our guest writers for their effort and the diverse and insightful viewpoints that they contributed to the world’s response to HIV and AIDS.

We will be re-featuring these articles over the next few weeks on a weekly basis. Browse through this week’s featured articles, and see the full list below.

The AIDS community is living in a time of ‘yes’. ‘Yes’ to our successes, ‘yes’ to our hopefulness and ‘yes’ to all we can achieve together. The latest UNAIDS report was entitled 'Together we will end AIDS'. The Washington DC Declaration called for an end to the pandemic. AIDS 2012 was convened under the theme 'Turning the Tide Together'. This sentiment is unprecedented; the days of doom and gloom are just a few scientific advances behind us. A victory against HIV, once merely a pipedream, now seems possible.

This wave of HIV optimism is perhaps most evident when discussing paediatric HIV. Yesterday we were consumed with efforts directed at children living with the dreaded disease – how to treat and care for them. Today, we’re talking about eradication of paediatric HIV. EMTCT (Elimination of Mother-To-Child Transmission) is the new buzz word. Prevention is the new black. The Global Plan, supported by ‘Believe it. Do it’, calls for elimination of new childhood infections by 2015. Talk about programmes for HIV-positive children - ‘Why?’ some ask. ‘There should be no paediatric HIV beyond 2015.’

And yet. While this ‘prevention-as-gold’ resolve is empowering, there are a few truths that are difficult to shake. The fact, for example, that last year just 57 percent of the 1.5 million HIV-positive pregnant women in low- and middle-income countries received effective ART to prevent transmission. Or the 330,000 children newly infected with HIV in the same year. It warrants mentioning that of the Global Plan's 22 priority countries, only 8 will actually achieve their target/s if their MTCT decline continues at the current rate.

What does all of this mean? If we examine the data, it seems we’re not heading for elimination of new paediatric infections any time soon. Really. This is not a pessimistic, glum view of our progress. It is simply an acknowledgement of what is true, right now, in the field.

“It’s not glamorous. It’s not exciting. It’s still sad. It’s still frustrating. But it’s true. And the allure of prevention, in all its glory, should not out-shadow or deprioritise the paediatric HIV treatment response.”

There are currently 3.4 million children under the age of 15 living with HIV globally. 3.4 million. Last year alone 230,000 children died from AIDS-related illnesses. 630 per day. Another truth – paediatric ART coverage is still at 28 percent. The reality is that most children who need treatment – treatment that’s been discovered, tested and even ‘rolled out’– do not receive it.

So while I concede that various markers of success are improved from previous years, and I think the optimism brave and commendable, we still have an incomprehensibly large population of children on treatment, a larger group in need of treatment, and more on the way. It’s not glamorous. It’s not exciting. It’s still sad. It’s still frustrating. But it’s true. And the allure of prevention, in all its glory, should not out-shadow or deprioritise the paediatric HIV treatment response.

If we want to be optimistic as an HIV community, I’d rather we get optimistic about the truth – single stories of transformation that mean more than the numbers. I have the privilege of spending my days at Paediatric AIDS Treatment for Africa (PATA), an action network of paediatric HIV clinic teams across sub-Saharan Africa. One of our proud achievements is an annual African frontline healthcare worker forum which culminates in attendees developing their own clinic goals and deliverables, each of which is reported on to PATA throughout the following year. The upshot? My inbox receives almost daily notice of the triumphs of doctors, nurses, counsellors and pharmacists. Small achievements, some might say, but I say not.

Hortencia, a doctor from Angola reported recently that her hospital has managed to reduce its waiting time from 3 hours to 3 minutes. Frank, a pharmacist from Tanzania wrote to say his clinic has traced back 16 children who had been lost from care. To me, these are the successes we should be talking about, working towards. These are the goals we should be getting behind, helping to actualise. Because they are true, they are possible and they are making a visible difference to the lives of hundreds of thousands of children.

There was a moment in 2009 – the week of the AIDS Vaccine Conference – that I will never forget. Paris, windy, biting. It was dusk, and I was walking the streets after a heavy day of back and forth between talk of what it would actually cost to put a vaccine in the supply chain and what it was costing to provide treatment. Pull, tug, pull. I was tired, cold and in need of a taxi, but there was none in sight. If I pushed it I could walk home, but I’d have to do so with determination and speed. Or, I could stand firm on the side of the road, more likely to spot a yellow vehicle but not making headway if I didn’t. My experience mirrored the day’s discussions. What I needed to do, I knew absolutely, was walk, slow and steady, looking over my shoulder for one of those yellow promises. It was a bit sticky, complicated and not the easiest to explain or commit to. But it was what was needed.

Today, three years later, I am reminded of that moment again. Let’s pursue the grand goals, commit to them, but not forget to keep walking. Let’s never lose sight of those millions of children still in need of our attention as we turn our sights to something greater. Let’s be optimistic about, but not blinded by our hope for the future. And let’s never forget the facts.

Dr Daniella Mark is Executive Director of Paediatric AIDS Treatment for Africa (PATA), an action network of 188 paediatric HIV clinic teams across sub-Saharan Africa. A neuropsychologist by training, she has a special interest in the intersection of HIV and neuropsychology. Dr Mark received BSocSc (Hons), MSocSc and PhD degrees from the University of Cape Town and is now an Honorary Research Associate in the University’s Department of Psychology. Having worked in the field of HIV for 8 years, Dr Mark has produced 40 publications and convention presentations in the areas of community acceptability and uptake of HIV prevention and treatment, stigma and adolescent health services.

For further information on HIV treatment for children see AVERT's page or read Kate Iorpenda's contribution to 'Reflections on the Epidemic'.

Images: 'Young people at AVERT's Sisonke project', copyright: AVERT. 'Daniella Mark' courtesy of PATA

Featured writers
In pursuit of a cure - Kevin Frost Ending paediatric AIDS: How we need to go beyond the clinical intervention when addressing children’s needs - Kate Iorpenda AIDS - it's not over - Dr Peter Piot The future of antiretroviral treatment - Dr Gottfried Hirnschall

All writers

Meeting the challenge of stigma in Iran
Dr Kamiar Alaei & Dr Arash Alaei
Physicians, winners of Elizabeth Taylor Award at AIDS 2012

Words are not enough: Where is the genuine support for an AIDS-free generation?
Georgia Arnold
Executive Director of the MTV Staying Alive Foundation

Narrow escape
Mercy Banda
Student, Malawi

Going beyond the silver bullet approach
Dr Alvaro Bermejo
Executive Director of the International HIV/AIDS Alliance

A new generation of awareness
AVERT
International HIV and AIDS Charity

Mothers at the forefront of change
Dr Mitchell Besser
Founder and Medical Director of mothers2mothers

A few simple actions against AIDS
Hydeia Broadbent
International HIV/AIDS Activist & Humanitarian

The reality of beginning the end of AIDS
Deborah Dugan
Chief Executive Officer of (RED)

In the balance — HIV and the Law
Dr Shereen El Feki
Vice-chair of the Global Commission on HIV and the Law

Striving for an AIDS free generation of adolescents
Lorrie Fair
Head of Programs, Charlize Theron Africa Outreach Project

A broken unity: An American reflection on the epidemic
Mary Fisher
Political activist, artist and author

Universal access for people who use drugs: Not just a pipe dream
Ann Fordham
Executive Director of the International Drug Policy Consortium (IDPC)

In pursuit of a cure
Kevin Frost
Chief Executive Officer, amfAR

The future of antiretroviral treatment
Dr Gottfried Hirnschall
Director of the HIV Department of WHO

Ending paediatric AIDS
Kate Iorpenda
Senior Advisor of Children and Impact Mitigation at the International HIV/AIDS Alliance

A future of possibilities
Gery Keszler
Chief Executive Officer of Life Ball

Riding the waves of HIV
Greg Louganis
Olympic Diver, Actor, Speaker and Activist

The Paediatric HIV response in the context of AIDS optimism
Dr Daniella Mark
Executive Director of Paediatric AIDS Treatment for Africa

HIV/AIDS Care begins at home
Dr Mosa Moshabela
Director of the Rural AIDS and Development Action Research (RADAR)

HIV/AIDS in Uganda: Myth to reality
Frank Mugisha
Executive Director of Sexual Minorities Uganda (SMUG)

Why beauty is a great weapon in the fight against HIV/AIDS
Ninette Murk
Founder and Creative Director of Designers Against AIDS and Beauty Without Irony

HIV Walk, unravels the epidemic
Catherine Murombedzi
Journalist who writes the column ‘HIV Walk’ in The Herald, Zimbabwe

The importance of Parliamentary voices in the AIDS response
Pamela Nash MP
Chair of the UK All Party Parliamentary Group on HIV and AIDS

Women breaking the stereotype
Kanya Ndaki
Editor of IRIN's HIV/AIDS news service PlusNews

Resources for a rights based approach to address the HIV/AIDS pandemic
David Odali
Executive Director of the Umunthu Foundation, partner of AVERT

AIDS - It’s not over
Professor Peter Piot
Director of London School of Hygiene and Tropical Medicine

Backing the community response
Midnight Poonkasetwattana
Executive Director of the Asia Pacific Coalition on Male Sexual Health (APCOM)

Gogo-getters become elders
Tony Schnell
Director of Sisonke, partner of AVERT

Getting to zero
Michel Sidibé
Executive Director of the Joint United Nations Programme on HIV/AIDS (UNAIDS)

The search for common humanity at the heart of the AIDS response
Ben Simms
Director of the UK Consortium on AIDS and International Development

AIDS is still hot in India
Dr Kutikuppala Surya Rao
Eminent HIV physician in India

Why involve women with HIV?
Dr Alice Welbourn
Founding Director of the Salamander Trust and activist

All opinions expressed in 'Reflections on the Epidemic' do not necessarily represent those of AVERT.